Launch of the Mount Sinai Robotics Institute
Thursday, November 17, 2016
Posted by: Julie Briggs
We are extremely pleased to share the launch of the Mount Sinai Robotics Institute (MSRI). This new institute within the Icahn School of Medicine at Mount Sinai will advance patient care through innovative, minimally invasive technology.
Mount Sinai’s world-renowned experts have employed robotic surgery for the treatment of a variety of conditions, including urological disease, oral and throat cancers, obstetrical conditions, and neurological disease. For more than 20 years, our groundbreaking work in these areas has distinguished our Health System as a leader in robotic and minimally invasive surgery. Educational programs and clinical research programs have been instrumental in achieving outstanding outcomes.
Through continuous optimization of robotic technology and multidisciplinary care, the MSRI will seek to further advance the field and achieve the best outcomes for patients. Its activities will include training students, resident, fellows, faculty, and peers from around the country and the world; patient education; clinical research and collaboration with global academic partners; database analytics and the study of health care outcomes; and research intended to assist in the development of new technology.
The Institute’s reach will be systemwide, encompassing the departments of Otolaryngology – Head and Neck Surgery, Urology, Obstetrics/Gynecology, Cardiology, Neurosurgery, Thoracic Surgery, and Surgery.
Two of our most highly esteemed experts in the field will co-chair the MSRI: Ash Tewari, MBBS, MCh, Kyung Hyun Kim Chair, Milton and Carroll Petrie Department of Urology, and Eric M. Genden, MD, MHCA, FACS, the Dr. Isidore Friesner Professor and Chair, Department of Otolaryngology—Head and Neck Surgery.
Dr. Genden performed the first transoral robotic surgery in New York in 2008 in advance of the U.S. Food and Drug Administration’s approval of the technique for head and neck cancer surgery in 2010, and since then, he and his team have enhanced the technology for removing tumors in the throat, tonsils, and base of the tongue to improve patient recovery, cosmetic appearance, and ability to speak and swallow.
Dr. Tewari developed the robotic prostate surgery technique called Advanced Robotic Technique prostatectomy or ART.® It is a highly individualized technique that reflects a patient’s unique anatomy, cancer location, and neural structure while removing cancer and minimizing side effects in select patients. Through ART, Dr. Tewari delicately removes the prostate while preserving sexual and urinary function.
Please join us in congratulating Drs. Tewari and Genden on their new roles as co-chairs of the Institute. We look forward to the future groundbreaking achievements of their dynamic team.
Read the full press release here.